HomeOwner SearchCategory Search
Visit USCOEstudio a corto plazo del anticuerpo monoclonal quimerico cA2 frente al factor alfa de necrosis tumoral para la enfermedad de Crohn Stephan R. Targan, Stephen B. Hanauer, Sander J. H. VanDeventer, Lloyd Mayer, Daniel H. Present, Tanja Braakman, Kimberly L. DeWoody, Thomas F. Schaible y Paul J. Rutgeerts
Text Registration
Copyright Title
Estudio a corto plazo del anticuerpo monoclonal quimerico cA2 frente al factor alfa de necrosis tumoral para la enfermedad de Crohn Stephan R. Targan, Stephen B. Hanauer, Sander J. H. VanDeventer, Lloyd Mayer, Daniel H. Present, Tanja Braakman, Kimberly L. DeWoody, Thomas F. Schaible y Paul J. Rutgeerts
Status
Published
on 14 Jun 2007
Year of Creation
2000
Copyright Claimant
Massachusetts Medical Society (employer for hire)
Registration Number
TX0005618972
on 14 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0005618972) dated 14 Jun 2007, pertains to an electronic file (eService) titled "Estudio a corto plazo del anticuerpo monoclonal quimerico cA2 frente al factor alfa de necrosis tumoral para la enfermedad de Crohn Stephan R. Targan, Stephen B. Hanauer, Sander J. H. VanDeventer, Lloyd Mayer, Daniel H. Present, Tanja Braakman, Kimberly L. DeWoody, Thomas F. Schaible y Paul J. Rutgeerts" created in 2000. The copyright holder is Massachusetts Medical Society (employer for hire), known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Massachusetts Medical Society (employer for hire).
Application Details
Registration Number
TX0005618972
Registration Date
6/14/2007
Year of Creation
2000
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Massachusetts Medical Society
Personal Authors
Notes
Host Item Entry: New England journal of medicine, Octubre 9, 1997
Local Copyright Note: C.O. correspondence
Previous Registration Note: Prev. reg. 1998, TX 4-609-885
© 2025 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.